Rat Vascular Cell Adhesion Molecule 1 (VCAM1) ELISA Kit

Assay Genie's quantitative immunoassay for rat vascular cell adhesion molecule 1 (VCAM1) gives laboratories a reproducible way to measure this inducible endothelial glycoprotein in experimental samples. VCAM1, also designated CD106, is upregulated on activated endothelium during inflammatory responses and mediates leukocyte adhesion to the vessel wall, making it a widely studied biomarker in vascular inflammation, atherosclerosis, transplant rejection, and immune cell trafficking research.

This kit is configured for 96 assays and validated for use with rat-derived specimens, including cell culture supernatants, tissue homogenates, cell lysates, and serum or plasma. The procedure follows a standard plate-based protocol with a colorimetric endpoint, and the reagents support routine in vitro laboratory work as well as dedicated research use only studies that demand batch-to-batch consistency across multiple runs.

Investigators working on models of cardiovascular disease, rheumatoid arthritis, endothelial activation, and chronic inflammation can integrate this assay into longitudinal study designs to track soluble VCAM1 levels across treatment groups, disease progression timepoints, or genetic backgrounds. Because VCAM1 expression is responsive to cytokine stimulation including TNF-alpha and IL-1, the assay is well suited to evaluate how candidate anti-inflammatory compounds modulate endothelial activation in rat model systems.